• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies on how exposure to ADHD for a long time could affect a foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the advantages of taking them against the potential risks to the fetus. Physicians don't have the data to provide clear recommendations but they can provide information about risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy did not have a greater risk of fetal malformations or structural birth defects. Researchers used a large sample-based case control study to examine the prevalence of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to reduce any bias.

The study conducted by the researchers was not without limitations. The most important issue was that they were unable to distinguish the effects of the medication from those of the disorder that is underlying. This makes it difficult for researchers to establish whether the small associations observed among the groups that were exposed to the use of medication or affected by co-morbidities. Additionally, the researchers did not look at long-term offspring outcomes.

The study showed that infants whose mother took ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean section or having a baby born with low Apgar score (less than 7). These risks did not seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medication during pregnancies in the early stages may be offset by the greater benefits to both mother and baby of continuing treatment for the woman's condition. Physicians should speak with their patients about this and as much as possible, assist them develop coping skills that could reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or stop treatment during pregnancy is a question that doctors are having to confront. These decisions are often made without clear and authoritative evidence. Instead, doctors have to take into account their own experience and experience, as well as the experiences of other doctors, and the research that has been conducted on the subject.

The issue of risk to infants is particularly tricky. The research on this subject is based on observation rather than controlled studies and many of the findings are in conflict. In addition, Most popular adhd medication studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study presented in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion A few studies have found a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies show a neutral, More hints or even slightly negative, effect. In the end, a careful risk/benefit assessment is required in every situation.

It isn't easy, but not impossible, for women suffering from best adhd medication for adults to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. The loss of medication can also impact the ability to drive safely and to perform work-related tasks which are crucial aspects of normal life for those with ADHD.

She suggests that women who are not sure whether to continue taking the medication or discontinue it due to pregnancy, educate their family members, coworkers and acquaintances about the condition, its impact on daily functioning and the benefits of continuing the current treatment. Educating them can also aid in ensuring that the woman feels supported in her struggle with her decision. It is also worth noting that certain drugs can pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be transferred to the child.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (getting adhd medication uk) grows there are concerns over the impact that these drugs might have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. With two massive data sets, researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study found no connection between early medication use and other congenital anomalies, like facial clefting, or club foot. The results are in agreement with previous studies that have shown a small, but significant increase in the number of cardiac malformations among women who began taking ADHD medication before the time of pregnancy. The risk grew during the latter part of pregnancy, when many women decide to stop taking their ADHD medications.

Women who used ADHD medications during the first trimester of their pregnancy were also more likely to undergo a caesarean section, a low Apgar score after delivery and a baby that required help breathing at birth. However, the authors of the study were not able to eliminate bias due to selection by restricting the study to women who did not have any other medical issues that could have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of doctors who encounter pregnant women. They recommend that, while a discussion of the risks and benefits is crucial, the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to look into, it is not recommended because of the high incidence of depression and mental health issues in women who are expecting or recently gave birth. Research has also shown that women who stop taking their medications will have a difficult time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience becoming a mother. Women suffering from ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to nursing infant is low because the majority of stimulant medications is absorbed through breast milk at a low level. The rate of exposure to medication will differ based on dosage, frequency of administration and the time of day. Additionally, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The effect on a newborn's health is not fully comprehended.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the woman who must weigh the advantages of continuing her medication against the potential risks to the foetus. Until more information becomes available, GPs may inquire about pregnant patients if they have an background of ADHD or if they are planning to take medication during the perinatal phase.

Many studies have shown that women can a general practitioner prescribe adhd medication continue to take their ADHD medication without risk during pregnancy and breast-feeding. In response, a rising number of patients are opting to continue their medication. They have found, in consultation with their physicians that the benefits of retaining their current medication outweigh risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be provided to help women with ADHD recognize their symptoms and the root cause and learn about treatment options and strengthen existing strategies for managing. This should include an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counselling should include the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.